leadf
logo-loader
viewMarrone Bio Innovations
(
NASDAQ:MBII
)

Marrone Bio Innovations new CEO Kevin Helash reveals uptick in quarterly earnings

Marrone Bio Innovations Inc (NASDAQ:MBII) new CEO Kevin Helash reveals uptick in second quarterly earnings, that doubled year-over-year.

Helash, who joins Marrone Bio from biological crop input provider Agrinos, says growing sales of its row crop treatments and other fungicides lead to the increase. He adds he's excited to take the company to its next level of success.

Quick facts: Marrone Bio Innovations

Follow
NASDAQ:MBII

Price: 0.989 USD

Market Cap: $174.35 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Marble Financial’s subsidiary Inverite Verification records 80,000 monthly...

Marble Financial CEO Karim Nanji joined Steve Darling from Proactive to share news its subsidiary, Inverite Verification has reported achieved record growth and transaction volume milestones. Nanji telling Proactive in August the company surpassed 80,000 monthly transactions and recorded an...

15 minutes ago

2 min read